A mulher erechinense atrav?s das representa??es na Revista de Erechim da d?cada de 1950

The present work has as its theme the representation of women in the Revista de Erechim referring to the decade of 1950. The analysis proposed came from the perspective of gender, studying the texts present in the Revista de Erechim directed to the women of the city of Erechim, Rio Grande southern half of the century. In order to reach the objectives of this research, a bibliographical survey was carried out regarding the gender studies in historiography, as well as documentary research in the Municipal Historical Archive Juarez Miguel Illa Font. The texts published by Revista de Erechim, Revista Revista Erechim, which played an important role in the dissemination of ideas, norms and behaviors to be followed by Erechian society as a whole, and in particular women, were analyzed. The research aimed to analyze what behaviors and attitudes were considered "adequate" to the ideals of modernity that were in vogue and the prescriptions of what was or was not acceptable in the behavior of women.O presente trabalho tem como tema a representa??o das mulheres na Revista de Erechim referente ? d?cada de 1950. A an?lise proposta se deu atrav?s da perspectiva de g?nero, estudando os textos presentes na Revista de Erechim direcionados ?s mulheres da cidade de Erechim, no Rio Grande do Sul da metade do s?culo. Para alcan?ar os objetivos desta pesquisa foi feito levantamento bibliogr?fico referente aos estudos de g?nero na historiografia, assim como pesquisa documental junto ao Arquivo Hist?rico Municipal Juarez Miguel Illa Font. Foram analisados os textos publicados pela Revista de Erechim, Revista esta que teve papel importante na divulga??o de ideias, normas e comportamentos a serem seguidos pela sociedade erechinense como um todo e, em particular as mulheres. A pesquisa objetivou analisar que comportamentos e atitudes eram considerados ?adequados? frente aos ideais de modernidade que estavam em voga e as prescri??es do que era ou n?o aceit?vel no comportamento das mulheres

Impact of dose and surface features on plasmatic and liver concentrations of biodegradable polymeric nanocapsules.

The effect of polymeric nanocapsule dose on plasmatic and liver concentrations 20 min after intravenous administration in mice was evaluated. Nanocapsules were prepared with different polymers, namely, poly(D,Llactide) (PLA), polyethylene glycol-block-poly(D,L-lactide) (PLA-PEG), and PLA with chitosan (PLA-Cs) and compared with a nanoemulsion. These formulations were labelled with a phthalocyanine dye for fluorescent detection. The nanostructures had narrow size distributions upon separation by asymmetric flow field flow fractionation with static and dynamic light scattering detection, with average hydrodynamic diameters in the 130?300 nm range, negative zeta potentials, except PLA-Cs nanocapsules, which had a positive zeta potential. Flow cytometry revealed uptake mostly by monocytes and neutrophils in mice and human blood. PLA nanocapsules and the nanoemulsion showed dose-dependent plasma concentrations, where the percentage of plasmatic fluorescence increased with increasing administered dose. In contrast, PLA-PEG nanocapsules led to a dose-independent plasmatic profile. PLA-Cs nanocapsules showed the lowest plasmatic and liver levels of fluorescence at all administered doses and significant intravenous toxicity in mice. This work demonstrates the importance of considering the nanocarrier dose when evaluating pharmacokinetic and biodistribution data and emphasizes the role of surface features in determining the plasmatic and liver concentrations of a poorly soluble lipophilic encapsulated compound

The institutions of archaic post-modernity and their organizational and managerial consequences: The case of Portugal

The long march of modernization of the Western societies tends to be presented as following a regular sequence: societies and institutions were pre-modern, and then they were modernized, eventually becoming post-modern. Such teleology may provide an incomplete or distorted narrative of societal evolution in many parts of the world, even in the ‘post-modern heartland’ of Western Europe, with Portugal being a case in point. The concept of archaic post-modernity has been developed by a philosopher, José Gil, to show how Portuguese institutions and organizations combine elements of pre-modernity and post-modernity. The notion of an archaic post-modernity is advanced in order to provide an alternative account of the modernization process, which enriches discussion of the varieties of capitalism. Differences in historical experiences create singularities that may be considered in the analysis of culture, management and organization

The first 80 days of the COVID-19 pandemic in the city of Belo Horizonte : from containment to reopening.

Este artigo examina o contexto e as implica??es da pandemia por Covid-19 na cidade de Belo Horizonte (BH) nos primeiros 80 dias da doen?a. Utilizamos um recorte anal?tico descritivo para mensurar a evolu??o dos casos, o excesso de ?bitos, a taxa de transmissibilidade do v?rus e a press?o da doen?a sobre o sistema de sa?de de BH e regi?o, atrav?s da taxa de ocupa??o hospitalar nos leitos p?blicos. Al?m disso, identificamos as principais pol?ticas de conten??o adotadas pelas autoridades locais, bem como as implica??es da redu??o do distanciamento social. Nossos resultados demonstram que o Sistema ?nico de Sa?de (SUS), bem gerido, ? fundamental para o enfrentamento da pandemia e a mitiga??o de suas consequ?ncias para a popula??o. O processo de flexibiliza??o que se inicia tem imposto novos desafios que requerer?o monitoramento atento das autoridades e da sociedade.The paper examines the implications of Co vid-19 pandemic for the city of Belo Horizonte (BH), during the fi rst 80 days of the disease. We use a descriptive-analytical approach to estimate the growth of Covid-19 cases over time, the excess of deaths, the virus? rate of transmissibility, and the consequent burden on the municipal the health system, measured by the rate of occupancy of public hospital beds. Also, we identify the main containment policies adopted by local authorities, and the implications of reopen ing measures and the following reduction of social distancing. Our fi ndings reveal that a well-managed Unifi ed Health System (SUS) is paramount to effectively tackle the pan demic and its consequences for the population. The reopening process has imposed new challenges that will require close monitoring by the authorities and by the Society

Design and baseline characteristics of the finerenone in reducing cardiovascular mortality and morbidity in diabetic kidney disease trial

Background: Among people with diabetes, those with kidney disease have exceptionally high rates of cardiovascular (CV) morbidity and mortality and progression of their underlying kidney disease. Finerenone is a novel, nonsteroidal, selective mineralocorticoid receptor antagonist that has shown to reduce albuminuria in type 2 diabetes (T2D) patients with chronic kidney disease (CKD) while revealing only a low risk of hyperkalemia. However, the effect of finerenone on CV and renal outcomes has not yet been investigated in long-term trials. Patients and Methods: The Finerenone in Reducing CV Mortality and Morbidity in Diabetic Kidney Disease (FIGARO-DKD) trial aims to assess the efficacy and safety of finerenone compared to placebo at reducing clinically important CV and renal outcomes in T2D patients with CKD. FIGARO-DKD is a randomized, double-blind, placebo-controlled, parallel-group, event-driven trial running in 47 countries with an expected duration of approximately 6 years. FIGARO-DKD randomized 7,437 patients with an estimated glomerular filtration rate >= 25 mL/min/1.73 m(2) and albuminuria (urinary albumin-to-creatinine ratio >= 30 to <= 5,000 mg/g). The study has at least 90% power to detect a 20% reduction in the risk of the primary outcome (overall two-sided significance level alpha = 0.05), the composite of time to first occurrence of CV death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for heart failure. Conclusions: FIGARO-DKD will determine whether an optimally treated cohort of T2D patients with CKD at high risk of CV and renal events will experience cardiorenal benefits with the addition of finerenone to their treatment regimen. Trial Registration: EudraCT number: 2015-000950-39; ClinicalTrials.gov identifier: NCT02545049